Key facts
- ACHV - ACHIEVE LIFE SCIENCES, INC. has 29 insiders with reported activity on this page.
- Net insider value flow over the last year: -$1,084,997.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 29 Insiders of ACHIEVE LIFE SCIENCES, INC.
- Symbol
- ACHV on Nasdaq
- Location
- Seattle, WA
Change
- Buy value: ; sell value: $1,084,996.
- Net share flow: -381,972.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$1,084,997.
Buys
$0
Shares: 0
Insiders: 0
Sells
$1,084,997
Shares: 381,972
Insiders: 6
Net
-$1,084,997
Shares: -381,972
Insiders: -6
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 381,972 | $0 | $1,084,997 | -$1,084,997 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
ACHIEVE LIFE SCIENCES, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jon Winkelried | 10%+ Owner | $20,220,085 | Median | 17 Apr 2026 | ||
| James G. Coulter | 10%+ Owner | $20,220,085 | Median | 17 Apr 2026 | ||
| TPG GP A, LLC | 10%+ Owner | $20,220,085 | Median | 17 Apr 2026 | ||
| DIALECTIC CAPITAL MANAGEMENT, LP | 10%+ Owner | $19,519,500 | Mixed | 18 Nov 2022 | ||
| Thomas B. King | Director | $2,542,793 | -$387,407 | -13% | Mixed | 04 Sep 2025 |
| Richard Alistair Stewart | Chief Executive Officer, Director | $1,250,261 | -$378,143 | -23% | Mixed | 18 Sep 2025 |
| Mark K. Oki | Chief Financial Officer | $990,144 | -$146,175 | -13% | Mixed | 18 Sep 2025 |
| Cindy Jacobs | President & CMO | $797,270 | -$76,532 | -8.8% | Mixed | 04 Sep 2025 |
| Jaime Xinos | Chief Commercial Officer | $573,176 | -$57,766 | -9.2% | Mixed | 04 Sep 2025 |
| John Bencich | CEO, Director | $369,334 | Mixed | 16 Aug 2024 | ||
| Jerry Wan | Principal Accounting Officer | $266,722 | -$38,974 | -13% | Mixed | 04 Sep 2025 |
| Mark Lawrence Rubinstein | Chief Medical Officer | $185,724 | Mixed | 01 Jan 2026 | ||
| Craig Donnelly | Chief Operations Officer | $165,495 | Mixed | 01 Oct 2025 | ||
| Anthony Clarke | Cso | $39,490 | Mixed | 28 Apr 2022 | ||
| Nancy R. Phelan | Director | Mixed | 06 Jun 2025 | |||
| SVB FINANCIAL GROUP | 10%+ Owner | Mixed | 18 Nov 2022 | |||
| Vaughn B. Himes | Director | Mixed | 22 Jan 2024 | |||
| Bridget A. Martell | Director | Mixed | 06 Jun 2025 | |||
| Kristen B. Slaoui | Director | Mixed | 06 Jun 2025 | |||
| Erik Atkisson | Chief Legal Officer | Mixed | 04 Dec 2025 | |||
| Andrew D. Goldberg | CEO and President, Director | Mixed | 18 Apr 2026 | |||
| Lucian Iancovici | Director | Mixed | 17 Apr 2026 | |||
| Martin A. Mattingly | Director | Mixed | 31 May 2022 | |||
| Jay M. Moyes | Director | Mixed | 31 May 2022 | |||
| Stuart Duty | Director | Mixed | 06 Jun 2025 | |||
| Aaron Royston | Director | Mixed | 17 Apr 2026 | |||
| Christopher Nathan Martin | Director | Mixed | 11 May 2026 | |||
| Donald Joseph | Director | Mixed | 31 May 2022 | |||
| Thomas Sellig | Director | Mixed | 06 Jun 2025 |
Top shareholders of ACHIEVE LIFE SCIENCES, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC |
13D/G
3/4/5
|
10%+ Owner |
13%
|
13,755,160
|
$40,440,170 | $0 | 17 Apr 2025 | |
| venBio Global Strategic Fund V, L.P. |
13D/G
|
— |
10%
|
10,737,317
|
$31,567,712 | $0 | 15 Apr 2026 | |
| Paradigm Biocapital Advisors LP |
13D/G
|
— |
9.2%
|
9,903,712
|
$29,116,913 | $0 | 17 Apr 2026 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
— |
6.5%
|
6,625,788
|
$19,479,817 | $0 | 17 Apr 2026 | |
| FRANKLIN RESOURCES INC |
13D/G
13F
|
Company |
6.2%
|
6,369,252
|
$22,801,922 | +$211 | 30 Apr 2026 | |
| Alyeska Investment Group, L.P. |
13D/G
|
— |
5.6%
|
2,982,722
|
$9,395,574 | -$6,098,715 | 30 Sep 2025 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
5.2%
|
5,502,064
|
$16,176,068 | $0 | 17 Apr 2026 | |
| VANGUARD GROUP INC |
13D/G
|
The Vanguard Group |
5%
|
1,717,014
|
$4,086,493 | $0 | 31 Mar 2025 | |
| Contrarian Alpha, LP |
13D/G
|
Parker Quillen |
4.9%
|
2,528,377
|
$7,964,388 | $0 | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
0.6%
from 13D/G
|
439,360
|
$1,291,718 | — | 31 Mar 2026 | |
| James G. Coulter |
3/4/5
|
10%+ Owner |
6.7%
|
6,877,580
|
$20,220,085 | — | 17 Apr 2026 | |
| Jon Winkelried |
3/4/5
|
10%+ Owner |
6.7%
|
6,877,580
|
$20,220,085 | — | 17 Apr 2026 | |
| Propel Bio Management, LLC |
13F
|
Company |
3.7%
|
3,786,425
|
$11,368,992 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.1%
|
2,204,714
|
$6,481,859 | — | 31 Mar 2026 | |
| Simplify Asset Management Inc. |
13F
|
Company |
1.2%
|
1,184,512
|
$3,482,465 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
1,077,338
|
$3,167,374 | — | 31 Mar 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.99%
|
1,019,281
|
$2,996,686 | — | 31 Mar 2026 | |
| LPL Financial LLC |
13F
|
Company |
0.71%
|
728,448
|
$2,141,637 | — | 31 Mar 2026 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.63%
|
648,885
|
$1,907,722 | — | 31 Mar 2026 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.62%
|
641,925
|
$1,887,259 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
622,785
|
$1,831,935 | — | 31 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.57%
|
588,551
|
$1,730,340 | — | 31 Mar 2026 | |
| KVP Capital Advisors, LP |
13F
|
Company |
0.45%
|
462,355
|
$1,359,324 | — | 31 Mar 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.37%
|
383,683
|
$1,128,028 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
326,270
|
$959,234 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.31%
|
316,177
|
$929,560 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
254,457
|
$748,104 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
224,742
|
$660,741 | — | 31 Mar 2026 | |
| Shay Capital LLC |
13F
|
Company |
0.2%
|
205,114
|
$603,035 | — | 31 Mar 2026 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.19%
|
200,000
|
$588,000 | — | 31 Mar 2026 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.17%
|
176,600
|
$519,204 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
152,952
|
$449,679 | — | 31 Mar 2026 | |
| Lakeside Advisors, INC. |
13F
|
Company |
0.11%
|
111,101
|
$326,637 | — | 31 Mar 2026 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.1%
|
101,971
|
$299,795 | — | 31 Mar 2026 | |
| Blue Trust, Inc. |
13F
|
Company |
0.08%
|
85,888
|
$252,511 | — | 31 Mar 2026 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.08%
|
84,896
|
$249,594 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
70,684
|
$207,811 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
70,378
|
$206,912 | — | 31 Mar 2026 | |
| MANCHESTER FINANCIAL INC |
13F
|
Company |
0.06%
|
66,222
|
$194,693 | — | 31 Mar 2026 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
56,118
|
$164,986 | — | 31 Mar 2026 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.05%
|
54,508
|
$160,254 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
52,420
|
$154,115 | — | 31 Mar 2026 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.05%
|
50,000
|
$147,000 | — | 31 Mar 2026 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
48,067
|
$141,317 | — | 31 Mar 2026 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.05%
|
47,800
|
$140,532 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
43,000
|
$126,420 | — | 31 Mar 2026 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.04%
|
37,760
|
$111,014 | — | 31 Mar 2026 | |
| Next Capital Management LLC |
13F
|
Company |
0.03%
|
34,995
|
$102,885 | — | 31 Mar 2026 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.03%
|
31,579
|
$92,000 | — | 31 Mar 2026 | |
| MEMBERS WEALTH LLC |
13F
|
Company |
0.03%
|
30,000
|
$126,900 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for ACHIEVE LIFE SCIENCES, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christopher Nathan Martin | ACHV | Stock Option (right to buy) | Award | 47,250 | 47,250 | 11 May 2026 | Direct | |||
| Andrew D. Goldberg | ACHV | Performance Restricted Stock Unit (PRSU) | Award | 11,706,270 | 11,706,270 | 18 Apr 2026 | Direct | |||
| Andrew D. Goldberg | ACHV | Stock Option (right to buy) | Award | 3,601,929 | 3,601,929 | 18 Apr 2026 | Direct | |||
| Andrew D. Goldberg | ACHV | Restricted Stock Unit (RSU) | Award | 1,800,965 | 1,800,965 | 18 Apr 2026 | Direct | |||
| Mark Lawrence Rubinstein | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Craig Donnelly | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Jaime Xinos | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Jerry Wan | ACHV | Stock Option (right to buy) | Award | 70,300 | 70,300 | 28 Jan 2026 | Direct | |||
| Richard Alistair Stewart | ACHV | Stock Option (right to buy) | Award | 645,000 | 645,000 | 28 Jan 2026 | Direct | |||
| Mark K. Oki | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Erik Atkisson | ACHV | Stock Option (right to buy) | Award | 250,000 | 250,000 | 04 Dec 2025 | Direct | |||
| Craig Donnelly | ACHV | Stock Option (right to buy) | Award | 50,000 | 50,000 | 01 Oct 2025 | Direct | |||
| Mark K. Oki | ACHV | Common Stock | Sale | -28.1% | $146,175 | $2.92 | -50,060 | 127,940 | 18 Sep 2025 | Direct |
| Mark K. Oki | ACHV | Common Stock | Options Exercise | 1680% | 168,000 | 178,000 | 18 Sep 2025 | Direct | ||
| Mark K. Oki | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -168,000 | 0 | 18 Sep 2025 | Direct | ||
| Richard Alistair Stewart | ACHV | Common Stock | Sale | -36.1% | $378,143 | $2.92 | -129,501 | 228,875 | 18 Sep 2025 | Direct |
| Richard Alistair Stewart | ACHV | Common Stock | Options Exercise | 488.7% | 297,500 | 358,376 | 18 Sep 2025 | Direct | ||
| Richard Alistair Stewart | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -297,500 | 0 | 18 Sep 2025 | Direct | ||
| Mark K. Oki | ACHV | Performance Restricted Stock Unit | Award | -100% | -168,000 | 0 | 04 Sep 2025 | Direct | ||
| Richard Alistair Stewart | ACHV | Performance Restricted Stock Unit | Award | -100% | -297,500 | 0 | 04 Sep 2025 | Direct | ||
| Jerry Wan | ACHV | Common Stock | Sale | -30.1% | $38,974 | $2.77 | -14,070 | 32,694 | 04 Sep 2025 | Direct |
| Jerry Wan | ACHV | Common Stock | Options Exercise | 269.3% | 34,100 | 46,764 | 04 Sep 2025 | Direct | ||
| Jerry Wan | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -34,100 | 0 | 04 Sep 2025 | Direct | ||
| Thomas B. King | ACHV | Common Stock | Sale | -30.7% | $387,407 | $2.77 | -139,858 | 315,142 | 04 Sep 2025 | Direct |
| Thomas B. King | ACHV | Common Stock | Options Exercise | 455,000 | 455,000 | 04 Sep 2025 | Direct | |||
| Thomas B. King | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -455,000 | 0 | 04 Sep 2025 | Direct | ||
| Cindy Jacobs | ACHV | Common Stock | Sale | -19.3% | $76,532 | $2.77 | -27,629 | 115,585 | 04 Sep 2025 | Direct |
| Cindy Jacobs | ACHV | Common Stock | Options Exercise | 331.2% | 110,000 | 143,214 | 04 Sep 2025 | Direct | ||
| Cindy Jacobs | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -110,000 | 0 | 04 Sep 2025 | Direct | ||
| Jaime Xinos | ACHV | Common Stock | Sale | -21.9% | $57,766 | $2.77 | -20,854 | 74,432 | 04 Sep 2025 | Direct |
| Jaime Xinos | ACHV | Common Stock | Options Exercise | 262.5% | 69,000 | 95,286 | 04 Sep 2025 | Direct | ||
| Jaime Xinos | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -69,000 | 0 | 04 Sep 2025 | Direct | ||
| Kristen B. Slaoui | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Nancy R. Phelan | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Thomas Sellig | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Bridget A. Martell | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Thomas B. King | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Stuart Duty | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.